Results 181 to 190 of about 3,265 (192)
Some of the next articles are maybe not open access.
Plasma anti-FDX1 autoantibody as a potential biomarker for detection and diagnosis of breast cancer
Clinical ImmunologyAutoantibodies have emerged as highly valuable biomarkers for cancer detection. Ferredoxin 1 (FDX1), a key cuproptosis regulator, significantly influences breast cancer prognosis. This study aimed to investigate whether the anti-FDX1 autoantibody can serve as a novel biomarker for breast cancer detection and diagnosis. Anti-FDX1 levels were detected in
Fangfang, Liu +3 more
openaire +2 more sources
High FDX1 expression enhances the sensitivity of multiple myeloma cells to elesclomol
BloodAbstract Background:Copper is an essential micronutrient required for regular physiological functions in the body. Dysregulated copper metabolism plays a crucial role in the progression of various types of cancer.
Hongyan Zhao +13 more
openaire +1 more source
Assignment of ferredoxin 1 (FDX1) to bovine chromosome 15 with somatic cell hybrids.
Cytogenetics and cell genetics, 19981 tables 1 graph.
Elduque, C., Eggen, Andre, A.
openaire +2 more sources
Anti-FDX1 Autoantibody as a Potential Biomarker for Non–Small Cell Lung Cancer Detection
Cancer Epidemiology, Biomarkers & PreventionAbstract Background: Autoantibodies can be readily identified prior to biopsy and may serve as valuable biomarkers for cancer detection. Ferredoxin 1 (FDX1) is a key regulator in the process of cuproptosis and affects the prognosis of lung cancer. In this study, we investigated whether the anti-
Jing Li +11 more
openaire +2 more sources
Functional genomics identifies a protective role for FDX1 in atherosclerosis
Nature Cardiovascular ResearchNicole Wayne, Marie A. Guerraty
openaire +2 more sources
Targeting the cuproptosis regulator FDX1 for cancer therapy
Genome Instability & DiseaseLuoling Wang, Weilin Chen
openaire +1 more source